HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Vascular Ehlers-Danlos syndrome: can the beneficial effect of celiprolol be extrapolated to bisoprolol?

AuthorsMaria C Gorosabel, Nicolo Dubacher, Janine Meienberg, Gabor Matyas
JournalEuropean heart journal. Cardiovascular pharmacotherapy (Eur Heart J Cardiovasc Pharmacother) Vol. 6 Issue 3 Pg. 199-200 (07 01 2020) ISSN: 2055-6845 [Electronic] England
PMID31693161 (Publication Type: Comparative Study, Letter)
Chemical References
  • Adrenergic beta-1 Receptor Antagonists
  • COL3A1 protein, mouse
  • Collagen Type III
  • Celiprolol
  • Bisoprolol
Topics
  • Adrenergic beta-1 Receptor Antagonists (pharmacology)
  • Aortic Dissection (genetics, physiopathology, prevention & control)
  • Animals
  • Aorta, Thoracic (drug effects, physiopathology)
  • Aortic Aneurysm, Thoracic (genetics, physiopathology, prevention & control)
  • Aortic Rupture (genetics, physiopathology, prevention & control)
  • Bisoprolol (pharmacology)
  • Celiprolol (pharmacology)
  • Collagen Type III (genetics)
  • Disease Models, Animal
  • Ehlers-Danlos Syndrome (drug therapy, genetics, physiopathology)
  • Humans
  • Mice, Transgenic
  • Mutation
  • Stress, Mechanical

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: